Literature DB >> 18237471

Relaxant action mechanism of berberine identified as the active principle of Argemone ochroleuca Sweet in guinea-pig tracheal smooth muscle.

María Elena Sánchez-Mendoza1, Carlos Castillo-Henkel, Andrés Navarrete.   

Abstract

In this study we investigated the relaxant effect of the aerial parts of Argemone ochroleuca (Papaveraceae), which is used in Mexican traditional medicine for the treatment of various respiratory diseases such as cough, bronchitis and asthma. The alkaloid berberine was identified as one of the active relaxant principles (EC50 = 118.50 +/-3.91 microM) in the dichloromethane extract of A. ochroleuca (EC50 = 78.03 +/- 2.15 microg mL(-1) with 95.12 +/- 3.56% of relaxation). Berberine concentration-dependently relaxed the carbachol-induced precontractions but not histamine- or KCl-induced precontraction. The relaxant effect of berberine was unaffected by the presence of propranolol (3 microM), glibenclamide (10 microM) or ODQ (10microM). However, 2', 5'-dideoxyadenosine (10 microM) blocked the log concentration-response curves of berberine. On the other hand, berberine produced a leftward shift of the log concentration-response curves of isoproterenol, forskolin and nitroprusside. Additionally, berberine produced a parallel rightward shift of the concentration-response curve of carbachol in a competitive manner with a pA2 of 3.87 +/- 0.045. The above results suggest that the relaxant effect of berberine on tracheal muscle is due to its antagonistic effect on muscarinic acetylcholine receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18237471     DOI: 10.1211/jpp.60.2.0012

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  8 in total

Review 1.  Unravelling the Therapeutic Potential of Botanicals Against Chronic Obstructive Pulmonary Disease (COPD): Molecular Insights and Future Perspectives.

Authors:  Sicon Mitra; Uttpal Anand; Mimosa Ghorai; Balachandar Vellingiri; Niraj Kumar Jha; Tapan Behl; Manoj Kumar; Mahipal S Shekhawat; Jarosław Proćków; Abhijit Dey
Journal:  Front Pharmacol       Date:  2022-05-11       Impact factor: 5.988

2.  In vitro anti-proliferative activity of Argemone gracilenta and identification of some active components.

Authors:  Mario Alberto Leyva-Peralta; Ramón Enrique Robles-Zepeda; Adriana Garibay-Escobar; Eduardo Ruiz-Bustos; Laura Patricia Alvarez-Berber; Juan Carlos Gálvez-Ruiz
Journal:  BMC Complement Altern Med       Date:  2015-02-05       Impact factor: 3.659

3.  Expectorant and antitussive effect of Hedera helix and Rhizoma coptidis extracts mixture.

Authors:  Kee Jae Song; Young-June Shin; Kang Ro Lee; Eun Jung Lee; Yun Suk Suh; Kyung-Su Kim
Journal:  Yonsei Med J       Date:  2015-05       Impact factor: 2.759

4.  Cortex phellodendri Extract Relaxes Airway Smooth Muscle.

Authors:  Qiu-Ju Jiang; Weiwei Chen; Hong Dan; Li Tan; He Zhu; Guangzhong Yang; Jinhua Shen; Yong-Bo Peng; Ping Zhao; Lu Xue; Meng-Fei Yu; Liqun Ma; Xiao-Tang Si; Zhuo Wang; Jiapei Dai; Gangjian Qin; Chunbin Zou; Qing-Hua Liu
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-27       Impact factor: 2.629

5.  Mechanism of action of relaxant effect of Agastache mexicana ssp.mexicana essential oil in guinea-pig trachea smooth muscle.

Authors:  Andrés Navarrete; Natalia Ávila-Rosas; Mateo Majín-León; José Luis Balderas-López; Alejandro Alfaro-Romero; José Carlos Tavares-Carvalho
Journal:  Pharm Biol       Date:  2016-09-22       Impact factor: 3.503

6.  Effects of a Mixture of Ivy Leaf Extract and Coptidis rhizome on Patients with Chronic Bronchitis and Bronchiectasis.

Authors:  Goohyeon Hong; Yu-Il Kim; Seoung Ju Park; Sung Yong Lee; Jin Woo Kim; Seong Hoon Yoon; Keu Sung Lee; Min Kwang Byun; Hak-Ryul Kim; Jaeho Chung
Journal:  Int J Environ Res Public Health       Date:  2021-04-12       Impact factor: 3.390

7.  Evaluation of food effects on the pharmacokinetics of Pelargonium sidoides and Coptis with each bioactive compound berberine and epicatechin after a single oral dose of an expectorant and antitussive agent UI026 in healthy subjects.

Authors:  Yewon Park; WonTae Jung; Eunsol Yang; Kyu-Yeol Nam; Woo-Ri Bong; Jaehee Kim; Kyu Yeon Kim; SeungHwan Lee; Joo-Youn Cho; Jang-Hee Hong; JaeWoo Kim
Journal:  Transl Clin Pharmacol       Date:  2022-03-07

8.  The vagal ganglia transcriptome identifies candidate therapeutics for airway hyperreactivity.

Authors:  Leah R Reznikov; David K Meyerholz; Mahmoud Abou Alaiwa; Shin-Ping Kuan; Yan-Shin J Liao; Nicholas L Bormann; Thomas B Bair; Margaret Price; David A Stoltz; Michael J Welsh
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-04-05       Impact factor: 5.464

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.